<li>ombitasvir/paritaprevir/ritonavir &amp; dasabuvir<p>clopidogrel will increase the level or effect of ombitasvir/paritaprevir/ritonavir &amp; dasabuvir by  decreasing metabolism. Contraindicated. Strong CYP2C8 inhibitors are shown to increase dasabuvir plasma concentrations (~10-fold), and therefore increase risk of QT prolongation</p></li>